Fundraising Fox
/Companies
Sign in

Ozette

Founded 2021 · 30 employees on LinkedIn · 13 known investors

Find your way into Ozette

Ozette runs a vertically integrated, AI-enabled lab and platform that generates high-dimensional spectral cytometry data and analyzes it to produce reproducible biomarker endpoints for clinical trials. It serves biopharma clinical development teams, discovery/R&D groups, and academic labs, operating under a validated (GCLP-compliant) quality system.

AI & Machine LearningBiotechHealthtech

Founders & leadership

Ozette was founded in 2021 by Greg Finak, Evan Greene, and Ali Ansary.

GFGreg Finak
Greg FinakFounder
EGEvan Greene
Evan GreeneCo-founder
AAAli Ansary
Ali AnsaryCo-founder

Investors · 13

Alpha Ascent Ventures Llclisted by Alpha Ascent Ventures LlcHong Kongvia Eric Greenberg · inferred

How we know: Alpha Ascent Ventures Llc's portfolio page · Not right? Tell us

M12 (Microsoft's Venture Fund)listed by M12 (Microsoft's Venture Fund)Seattle · $100K – $10M

How we know: M12 (Microsoft's Venture Fund)'s portfolio page · Not right? Tell us

AlexandriareportedPasadena

How we know: biospace.com · Not right? Tell us

Cercano ManagementreportedBellevue

How we know: biospace.com · Not right? Tell us

Madrona Venture GroupreportedSeattle · $2M – $10M

How we know: funding news · Not right? Tell us

OCV PartnersreportedLos Angeles

How we know: biospace.com · Not right? Tell us

Also in the syndicate · 6

AI2Duke UniversityM12MadronaMadrona VenturesleadVulcan

Funding

SEC filings, press & company announcements

$32M disclosed across 2 of 4 rounds · 2021–2022

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap
SoundCloud3 shared keywordsAudio distribution and music-sharing platform for artists and creators.
Incyte Corporation3 shared keywordsIncyte is a biopharmaceutical company that develops and commercializes medicines for oncology, hematology, dermatology, and other therapeutic areas. The company focuses on bringing treatments to patients across multiple disease categories.

Companies competing with Ozette for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Seattle biotech Ozette raises $26M round led by Madrona - Puget Sound Business Journalbizjournals.com · Aug 2022Ozette Raises $26M in Series A Fundingfinsmes.com · Jul 2022Ozette Announces $26MM in Series A Funding for AI-Powered Single-Cell Immune Discovery Technology that Accelerates Therapeutics Across Research and Development - BioSpacebiospace.com · Jul 2022Ozette raises $6 million for immune system-monitoring tech | VentureBeatventurebeat.com · Feb 2021Fred Hutch biotech spinout Ozette raises $6M from Madrona, AI2, Vulcan – GeekWiregeekwire.com · Feb 2021Ozette raises $6M seed funding to accelerate breakthroughs in treating diseases using its AI-powered immune monitoring platform - Tech Startupstechstartups.com · Feb 2021

Frequently asked questions

What does Ozette do?
Ozette runs a vertically integrated, AI-enabled lab and platform that generates high-dimensional spectral cytometry data and analyzes it to produce reproducible biomarker endpoints for clinical trials. It serves biopharma clinical development teams, discovery/R&D groups, and academic labs, operating under a validated (GCLP-compliant) quality system.
Who founded Ozette?
Ozette was founded by Greg Finak, Evan Greene, Ali Ansary in 2021.
Who are Ozette's investors?
Ozette's investors include Allen Institute for AI (AI2) Incubator, Alpha Ascent Ventures Llc, M12 (Microsoft's Venture Fund), Alexandria, Cercano Management, Madrona Venture Group, OCV Partners.
How much funding has Ozette raised?
Ozette has disclosed $32M raised across 2 of its 4 known rounds.